During the past decade, Cancerologia de Queretaro S.C. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cancerologia de Queretaro S.C." are "Follicular Lymphoma" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Cancerologia de Queretaro S.C." in a lesser frequency.

Most popular intervention types in "Cancerologia de Queretaro S.C." are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Herceptin®" (1 trials), "MabThera®" (1 trials), "PF-05280014" (1 trials), "PF-05280586" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cancerologia de Queretaro S.C." are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cancerologia de Queretaro S.C.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cancerologia de Queretaro S.C., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cancerologia de Queretaro S.C., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".